Related Experiment Video
Updated: Oct 5, 2025

09:46
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
4.9K
Local autoimmune encephalomyelitis model in a rat brain with precise control over lesion placement
Lukasz Kalkowski1, Dominika Golubczyk1, Joanna Kwiatkowska1
1Department of Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.
Plos One
|January 21, 2022
Summary
Researchers developed a new animal model for multiple sclerosis (MS) by combining demyelination and experimental autoimmune encephalomyelitis (EAE) to create local autoimmune encephalomyelitis (LAE) in rats, enabling reproducible lesion development for treatment discovery.
Area of Science:
- Neuroscience
- Immunology
- Animal Models
Background:
- Multiple sclerosis (MS) treatment discovery requires reliable animal models.
- Current models often lack reproducibility and predictable lesion localization.
- Combining demyelination with experimental autoimmune encephalomyelitis (EAE) offers a potential solution.
Purpose of the Study:
- To develop a novel, reproducible animal model for MS research.
- To create a localized autoimmune encephalomyelitis (LAE) in the rat brain.
- To facilitate the discovery of effective MS therapies.
Main Methods:
- Male Wistar rats were immunized against myelin epitopes.
- Blood-brain barrier opening was induced using vascular endothelial growth factor via stereotactic injection.
- Histological assessments were performed at 3 and 7 days post-injection.
Main Results:
- Immunization confirmed reactivity against myelin epitopes.
- Stereotactic injection successfully induced demyelinating lesions.
- Lesion development was observed with high reproducibility and low morbidity.
Conclusions:
- The developed local autoimmune encephalomyelitis (LAE) model provides a reproducible method for studying MS.
- This novel model aids in understanding demyelination and autoimmune responses in the brain.
- The model's predictability and low morbidity support its utility in preclinical MS research.

